Literature DB >> 1600943

Enhanced binding of a 95 kDa protein to p53 in cells undergoing p53-mediated growth arrest.

Y Barak1, M Oren.   

Abstract

To explore the biochemical functions of p53, we have initiated a search for cellular p53-binding proteins. Coprecipitation of three polypeptides was observed when cell lines overexpressing a temperature-sensitive (ts) p53 mutant were maintained at 32.5 degrees C (wild-type p53 activity, leading to growth arrest) but not at 37.5 degrees C (mutant p53 activity). One of these three proteins, designated p95 on the basis of its apparent molecular mass, was highly abundant in p53 immune complexes. We demonstrate herein that p95 is a p53-binding protein, which exhibits poor p53-binding in cells overproducing several distinct mutant p53 proteins. Yet, p95 associates equally well with both the wild-type (wt) and the mutant conformations of the ts p53 in transformed cells growth-arrested at 32.5 degrees C. On the basis of our findings we suggest that wt p53 activity increases p53-p95 complex formation and that such interaction may play a central role in p53 mediated tumour suppression.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1600943      PMCID: PMC556678          DOI: 10.1002/j.1460-2075.1992.tb05270.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  58 in total

1.  Mouse p53 inhibits SV40 origin-dependent DNA replication.

Authors:  A W Braithwaite; H W Sturzbecher; C Addison; C Palmer; K Rudge; J R Jenkins
Journal:  Nature       Date:  1987 Oct 1-7       Impact factor: 49.962

2.  Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factor.

Authors:  L R Bandara; N B La Thangue
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

3.  Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication.

Authors:  J Bargonetti; P N Friedman; S E Kern; B Vogelstein; C Prives
Journal:  Cell       Date:  1991-06-14       Impact factor: 41.582

4.  The E2F transcription factor is a cellular target for the RB protein.

Authors:  S P Chellappan; S Hiebert; M Mudryj; J M Horowitz; J R Nevins
Journal:  Cell       Date:  1991-06-14       Impact factor: 41.582

5.  Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product.

Authors:  W G Kaelin; D C Pallas; J A DeCaprio; F J Kaye; D M Livingston
Journal:  Cell       Date:  1991-02-08       Impact factor: 41.582

6.  Mutant p53 proteins bind DNA abnormally in vitro.

Authors:  S E Kern; K W Kinzler; S J Baker; J M Nigro; V Rotter; A J Levine; P Friedman; C Prives; B Vogelstein
Journal:  Oncogene       Date:  1991-01       Impact factor: 9.867

7.  Localization of p53, retinoblastoma and host replication proteins at sites of viral replication in herpes-infected cells.

Authors:  D Wilcock; D P Lane
Journal:  Nature       Date:  1991-01-31       Impact factor: 49.962

Review 8.  Tumor suppressor genes.

Authors:  R A Weinberg
Journal:  Science       Date:  1991-11-22       Impact factor: 47.728

9.  Analysis of p53 mutants for transcriptional activity.

Authors:  L Raycroft; J R Schmidt; K Yoas; M M Hao; G Lozano
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

10.  The retinoblastoma protein copurifies with E2F-I, an E1A-regulated inhibitor of the transcription factor E2F.

Authors:  S Bagchi; R Weinmann; P Raychaudhuri
Journal:  Cell       Date:  1991-06-14       Impact factor: 41.582

View more
  30 in total

Review 1.  Mdm2: the ups and downs.

Authors:  T Juven-Gershon; M Oren
Journal:  Mol Med       Date:  1999-02       Impact factor: 6.354

2.  Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding.

Authors:  E Shaulian; A Zauberman; D Ginsberg; M Oren
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

3.  MDM2 is a target of simian virus 40 in cellular transformation and during lytic infection.

Authors:  W Henning; G Rohaly; T Kolzau; U Knippschild; H Maacke; W Deppert
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis.

Authors:  S N Jones; A R Hancock; H Vogel; L A Donehower; A Bradley
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

5.  MDMX: a novel p53-binding protein with some functional properties of MDM2.

Authors:  A Shvarts; W T Steegenga; N Riteco; T van Laar; P Dekker; M Bazuine; R C van Ham; W van der Houven van Oordt; G Hateboer; A J van der Eb; A G Jochemsen
Journal:  EMBO J       Date:  1996-10-01       Impact factor: 11.598

6.  The p53 status of Chinese hamster V79 cells frequently used for studies on DNA damage and DNA repair.

Authors:  W Chaung; L J Mi; R J Boorstein
Journal:  Nucleic Acids Res       Date:  1997-03-01       Impact factor: 16.971

7.  Physical and functional interaction between wild-type p53 and mdm2 proteins.

Authors:  D S Haines; J E Landers; L J Engle; D L George
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

8.  p53 domains: suppression, transformation, and transactivation.

Authors:  M Reed; Y Wang; G Mayr; M E Anderson; J F Schwedes; P Tegtmeyer
Journal:  Gene Expr       Date:  1993

9.  Therapeutic strategies for head and neck cancer based on p53 status.

Authors:  Ichiro Ota; Noritomo Okamoto; Katsunari Yane; Akihisa Takahashi; Takashi Masui; Hiroshi Hosoi; Takeo Ohnishi
Journal:  Exp Ther Med       Date:  2012-02-03       Impact factor: 2.447

10.  Estrogen receptor-dependent proteasomal degradation of the glucocorticoid receptor is coupled to an increase in mdm2 protein expression.

Authors:  H Karimi Kinyamu; Trevor K Archer
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.